Protozoan Infections of the Gastrointestinal Tract

Infectious Disease Clinics of North America

Volumn 26, Issue 2, 2012, Pages 323-339

  Wright, Stephen G ^a  

^a Private Consulting Rooms   (United Kingdom)

Author keywords

Gastrointestinal tract; Infection; Parasites; Protozoan

Indexed keywords

ALBENDAZOLE; COTRIMOXAZOLE; DILOXANIDE FUROATE; MEPACRINE; METRONIDAZOLE; NITAZOXANIDE; ORNIDAZOLE; PAROMOMYCIN; SECNIDAZOLE; TINIDAZOLE;

AMEBIASIS; CLINICAL FEATURE; COLON PERFORATION; CRYPTOSPORIDIOSIS; CYCLOSPORIASIS; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL INFECTION; GEOGRAPHIC DISTRIBUTION; GIARDIASIS; HUMAN; INFECTION PREVENTION; KERATITIS; LIFE CYCLE; MICROSPORIDIOSIS; NONHUMAN; PARASITE TRANSMISSION; PROTOZOAL INFECTION; REVIEW; STUNTING;

ANIMALS; ANTIPROTOZOAL AGENTS; DIAGNOSIS, DIFFERENTIAL; GASTROINTESTINAL DISEASES; HUMANS; INTESTINAL DISEASES, PARASITIC; LIFE CYCLE STAGES; PROTOZOAN INFECTIONS;

EID: 84861473630     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2012.03.009     Document Type: Review

References (66)

1. Rendtorff C.E. The experimental transmission of human intestinal protozoan parasites II Giardia lamblia cysts given in capsules. Am J Hyg 1954, 59:209-220.
2. Rice E.W. Schaefer III Improved in vitro excystation procedure for Giardia lamblia cysts. J Clin Microbiol 1981, 14:709-710.
3. Abel E.S., Davids B.J., Robles L.D., et al. Possible roles of protein kinase A in cell motility and excystation of the early diverging eukaryote Giardia lamblia. J Biol Chem 2001, 276:10320-10329.
4. Birkeland S.R., Preheim S.P., Davids B.J., et al. Transcriptome analysis of the Giardia lamblia life cycle. Mol Biochem Parasitol 2010, 174:62-65.
5. Binz N., Thompson R.C., Lymbery A.J., et al. Comparative studies on the growth dynamics of two genetically distinct isolates of Giardia duodenalis in vitro. Int J Parasitol 1992, 22:195-202.
6. Ferguson A., Gillon J., Al Thamery D. Intestinal abnormalities in murine giardiasis. Trans R Soc Trop Med Hyg 1980, 74:445-448.
7. Yu-Jiao P., Chao-Cheng C., Yu-Yun K., et al. A novel WRKY-like protein involved in transcriptional activation of cyst wall protein genes in Giardia lamblia. J Biol Chem 2009, 284:17975-17988.
8. Morf L.M., Spycher C., Rehrauer H., et al. The transcription response to encystation stimuli by Giardia lamblia is restricted to a small set of genes. Eukaryot Cell 2010, 9:1566-1576.
9. Porter J.D., Ragazzoni H.P., Buchanon J.D., et al. Giardia transmission in a swimming pool. Am J Public Health 1988, 78(6):659-662.
10. Dykes A.C., Juranek D.D., Lorenz R.A., et al. Municipal waterborne giardiasis: an epidemiologic investigation. Beavers implicated as a possible reservoir. Ann Intern Med 1980, 92(2 Pt 1):165-170.
11. Barbour A.G., Nichols C.R., Fukushima T. An outbreak of giardiasis in a group of campers. Am J Trop Med Hyg 1980, 25:384-389.
12. Caccio S.M., Ryan U. Molecular epidemiology of giardiasis. Mol Biochem Parasitol 2008, 160:75-80.
13. Jerlström-Hutqvits J., Anarklev J., Staffan S.G. Is human giardiasis caused by two different Giardia species?. Gut Microbes 2010, 1:379-382.
14. Jokipii A.M., Jokipii L. Prepatency of giardiasis. Lancet 1977, 1:1095-1097.
15. Wright S.G., Tomkins A.M., Ridley D.S. Giardiasis: clinical and therapeutic aspects. Gut 1977, 18:343-350.
16. Katelaris P., Seow F., Ngu M. The effect of Giardia lamblia trophozoites on lipolysis in vitro. Parasitology 1991, 103:35-39.
17. Farthing M.J., Pereira M.E., Keusch G.T. Description and characterization of a surface lectin from Giardia lamblia. Infect Immun 1986, 51:661-677.
18. Chin A.C., Teoh D.A., Scott K.G., et al. Strain-dependent induction of enterocyte apoptosis by Giardia lamblia disrupts epithelial barrier function in a caspase - 3 dependent manner. Infect Immun 2007, 70:3673-3680.
19. Panaro M.A., Cianciulli A., Mitolo V., et al. Caspase dependent apoptosis of the HCT-8 epithelial cell line induced by the parasite Giardia intestinalis. FEMS Immunol Med Microbiol 2007, 51:302-309.
20. Troeger H., Epple H.J., Schneider T., et al. Effect of chronic Giardia lamblia infection on epithelial transport and barrier function in human duodenum. Gut 2007, 56:328-335.
21. Oberhuber G., Stolte M. Histologic detection of trophozoites of Giardia lamblia in the terminal ileum. Scand J Gastroenterol 1995, 30:905-908.
22. Calderaro A., Gorrini C., Montecchini S., et al. Evaluation of a real-time polymerase chain reaction assay for the laboratory diagnosis of giardiasis. Diagn Microbiol Infect Dis 2010, 66:261-267.
23. Sackey M.E., Weigel M.M., Armijos R.X. Predictors and nutritional consequences of intestinal parasitic infections in rural Ecuadorian children. J Trop Pediatr 2003, 49:17-23.
24. Berkman D.S., Lescano A.G., Gilman R.H., et al. Effects of stunting, diarrhoeal disease and parasitic infection during infancy on cognition in late childhood: a follow up study. Lancet 2002, 359:564-571.
25. Jokipii L., Jokipii A.M. Single-dose metronidazole and tinidazole as therapy for giardiasis: success rates, side effects, and drug absorption and elimination. J Infect Dis 1979, 140(6):984-988.
26. Mørch K., Hanevik K., Robertson L.J., et al. Treatment-ladder and genetic characterization of parasites in refractory giardiasis after an outbreak in Norway. J Infect 2008, 56(4):268-273.
27. Klein P., Kleinová T., Volek Z., et al. Effect of Cryptosporidium parvum infection on the absorptive capacity and paracellular permeability of the small intestine in neonatal calves. Vet Parasitol 2008, 152:53-59.
28. Garza A., Lackner A., Aye P., et al. Substance P receptor antagonist reverses intestinal pathophysiological alterations occurring in a novel ex-vivo model of Cryptosporidium parvum infection of intestinal tissues derived from SIV-infected macaques. J Med Primatol 2008, 37:109-115.
29. Robinson P., Okhuysen P.C., Cappell C.L., et al. Substance P expression correlates with severity of diarrhea in cryptosporidiosis. J Infect Dis 2003, 188:290-296.
30. Castellano-Gonzalez A., Yancey L.S., Wang H.C., et al. Cryptosporidium infection of human intestinal epithelial; cells increases expression of osteoprotegerin: a novel mechanism for evasion of host defense. J Infect Dis 2008, 197:916-923.
31. DuPont H.L., Chappell C.L., Sterling C.R., et al. The infectivity of Cryptosporidium parvum tin healthy volunteers. N Engl J Med 1995, 332:855-859.
32. Sattar S.A., Chauret C., Springthorpe V.S., et al. Giardia cyst and Cryptosporidium oocyst survival in watersheds and factors affecting inactivation 1999, American Water Works Association Research Foundation, Denver (CO), p. 1-10.
33. Blanshard C., Jackson A.M., Shanson D.C., et al. Cryptosporidiosis in HIV-seropositive patients. Q J Med 1992, 85:813-823.
34. MacKenzie W.R., Hoxie N.J., Proctor M.E., et al. A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. N Engl J Med 1994, 331:161-167.
35. Molbak K., Hojlyng N., Ingholt L., et al. An epidemic of cryptosporidiosis: a prospective community study from Guinea Bissau. Pediatr Infect Dis J 1990, 9:566-570.
36. Siwila J., Ohiri I.G., Enemark H.L., et al. Seasonal prevalence and incidence of Cryptosporidium spp and Giardia duodenalis and associated diarrhoea in children attending pre-school in Kafue, Zambia. Trans R Soc Trop Med Hyg 2011, 105:102-108.
37. Cama V.A., Bern C., Roberts J., et al. Cryptosporidium species and subtypes and clinical manifestations in children, Peru. Emerg Infect Dis 2008, 14:1567-1574.
38. Hadfield S.J., Robinson G., Elwin C., et al. Detection and differentiation of Cryptosporidium spp. In clinical samples by use of real time PCR. J Clin Microbiol 2011, 49:918-924.
39. Rossignol J.F., Ayoub A., Ayer M.S. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized double-blind placebo-controlled study of nitazoxanide. J Infect Dis 2001, 184:103-106.
40. Amadi B., Mwiya M., Musuku J., et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomized controlled trial. Lancet 2002, 360:1375-1380.
41. Sargeaunt P., Williams P., Greene J.D. The differentiation of invasive and non-invasive Entamoeba histolytica by isoenzyme electrophoresis. Trans R Soc Trop Med Hyg 1978, 72:519-521.
42. Tannich E., Horstmann R.D., Knobloch J., et al. Genomic differences between pathogenic and nonpathogenic Entamoeba histolytica. Proc Natl Acad Sci U S A 1989, 86:5118-5122.
43. Diamond L.S., Clarke C.G. A redescription of Entamoeba histolytica Schaudin 1903 (Emended Walker 1911) to separate Entamoeba histolytica it from Entamoeba dispar (Brumpt 1925). J Eukaryot Microbiol 1993, 40:340-344.
44. Zhang X., Zhang Z., Alexander D., et al. Expression of amoebapore is required for full expression of Entamoeba histolytica virulence in amebic liver abscess but is not necessary for the induction of inflammation or tissue damage in amebic colitis. Infect Immun 2004, 72:678-683.
45. James R., Barratt J., Marriott D., et al. Seroprevalence of Entamoeba histolytica among men who have sex with men in Sydney Australia. Am J Trop Med Hyg 2010, 83:914-916.
46. Haque R., Mondal D., Karim A., et al. Prospective case control study of the association between common enteric protozoal parasites and diarrhea in Bangladesh. Clin Infect Dis 2009, 48:1191-1197.
47. Blessmann J., Ibne K., Phuong A., et al. Longitudinal study of intestinal Entamoeba histolytica infections in asymptomatic adult carriers. J Clin Microbiol 2003, 41:4745-4750.
48. Nishise S., Fiujishima T., Kobayashi S., et al. Mass infection with Entamoeba histolytica in a Japanese institution for individuals with mental retardation: epidemiology and control measures. Ann Trop Med Parasitol 2010, 104:383-390.
49. Herbinger K.H., Fleischmann E., Weber C., et al. Epidemiological, clinical and diagnostic data on intestinal infections with Entamoeba histolytica and Entamoeba dispar among returning travelers. Infection 2011, 39(6):527-535.
50. Takahashi T., Gambon-Dominguez A., Gomez-Mendez T.J., et al. Fulminant amebic colitis: an analysis of 55 cases. Dis Colon Rectum 1997, 40:1362-1367.
51. McGregor A., Brown M., Thway K., et al. Fulminant amoebic colitis following loperamide use. J Travel Med 2007, 14:61-62.
52. Watanabe K., Gatanag H., Escueta de Cadiz A., et al. Amebiasis in HIV-1 infected Japanese men: clinical features and response to therapy. PLoS Negl Trop Dis 2011, 5:e13418.
53. Lodhi S., Sarwar A.R., Muzammil M., et al. Features distinguishing amoebic liver abscess from pyogenic liver abscess: a review of 577 cases. Trop Med Int Health 2004, 9:718-723.
54. Gonzalez M.L., Dans L.F., Martinez E.G. Antiamoebic drugs for treating amoebic colitis. Cochrane Database Syst Rev 2009, 15. CD006085.
55. Blessmann J., Binh H.D., Hung D.M., et al. Treatment of amoebic liver abscess with metronidazole alone or in combination with ultrasound-guided needle aspiration: a comparative, prospective and randomized study. Trop Med Int Health 2003, 8:1030-1034.
56. Chavez-Tapia N.C., Hernandez-Callerros J., Tellez-Avila F.I., et al. Image-guided procedure plus Metronidazole versus Metronidazole alone for uncomplicated amebic liver abscess. Cochrane Database Syst Rev 2009, 1. CD00488.
57. Blessmann J., Tannich E. Treatment of asymptomatic intestinal Entamoeba histolytica infection. N Engl J Med 2002, 347:1384.
58. Ortega Y.R., Sanchez R. Update on cyclosporiasis: a food-borne and waterborne parasite. Clin Microbiol Rev 2010, 23:218-234.
59. Moretto M., Weiss L.M., Combe C.L., et al. IFN-Y producing dendritic cells are important for priming of gut intraepithelial lymphocyte response against intracellular parasitic infection. J Immunol 2007, 179:2485-2492.
60. Goodgame R., Stager C., Marcantel B., et al. Intensity of infection in AIDS-related intestinal microsporidiosis. J Infect Dis 1999, 180:929-932.
61. Izquierdo F., Catillo Hermida J.A., Fenoy S., et al. Detection of microsporidia in drinking water, waste water and recreational rivers. Water Res 2011, 45:4837-4843.
62. Slodkowicz-Kowalska A. Animal reservoirs of human virulent microsporidian species. Wiad Parazytol 2009, 55:63-65.
63. Cama V., Pearson J., Cabrera L., et al. Transmission on Enterocytozoon bieneusi between a child and guinea pigs. J Clin Microbiol 2007, 45:2708-2710.
64. Dworkin M.S., Buskin S.E., Davidson A.J., et al. Prevalence of intestinal microsporidiosis in human immunodeficiency virus infected patients with diarrhea in major United States cities. Rev Inst Med Trop Sao Paulo 2007, 49:339-342.
65. Wolk D.M., Schneider S.K., Wengwenack N.L., et al. Real time PCR for detection of Encephalitozoon intestinalis from stool samples. J Clin Microbiol 2002, 40:3922-3928.
66. Tremoulet A.H., Avila-Aguero M.L., Paris M.M., et al. Albendazole therapy for Microsporidium diarrhea in immunocompetent children. Pediatr Infect Dis J 2004, 23:915-918.